Business
First ASX debut of 2021 off to a bang as TruScreen pops – Stockhead
Kiwi cervical cancer screening company TruScreen (ASX:TRU) has made a strong debut on the ASX and is now dual-listed. At 11.48 am, TRU shares were trading at 9c…
Link copied toclipboard
Kiwi cervical cancer screening company TruScreen (ASX:TRU) has made a strong debut on the ASX and is now dual-listed.
At 11.48 am, TRU shares were trading at 9c and earlier had reached as high as 9.9c, following a “compliance IPO” in which TruScreen raised about $1.9 million at NZ7c or 6.5c a share.
The company has been listed on the NZX since 2014 and its ASX listing brings back Australian medical technology to Australia.
TruScreen makes a pen-like digital wand that is placed…
-
General23 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
Business15 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
General10 hours agoLiberals go back to basics after crawling to year’s end
-
Business15 hours ago3 of the best ASX ETFs to build significant wealth